INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 417m ago
House PTR17m ago
SEC 13F16m ago
Robinhood Chain16m ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,706 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
FP
Fredrickson David PaulDirector
CAICaris Life Sciences, Inc.
Grant or award
A—
13.2K sh
Aug 14, 2026Aug 14, 2026
Page 506 of 1693
← PrevNext →
traded Aug 14, 2026
+0d
SEC Form 4

Evidence

21
GE
Gilliam Joseph EDirector
CAICaris Life Sciences, Inc.
Grant or award
A—
13.2K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

21
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Option exercise
M—
272.1K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

21
ML
Minor LloydDirector
CAICaris Life Sciences, Inc.
Grant or award
A—
13.2K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

20
RH
Ramani HiteshChief Accounting Officer
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$413K
25.0K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

20
JJ
Jergensen JoshuaPresident & COO
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$1.66M
36.4K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

20
MA
Mancini Christopher AndrewSVP OF PROF SALES & STORE OPS
ORLYO REILLY AUTOMOTIVE INC
Option exercise
M$50K
3,000 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

20
WF
Weir Daniel FDirector
TFSLTFS Financial CORP
Gift
G—
5,000 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

20
HJ
Hyman JonathanChief Technology Officer
BRZEBraze, Inc.
Open-market sale · 10b5-1 plan
SELL$1.05M
35.0K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

19
WA
Wegner AlpanaChief Financial Officer
WAYWaystar Holding Corp.
Grant or award
A—
162.1K sh
Jul 24, 2026Aug 14, 2026
traded Jul 24, 2026
+21dSEC Form 4

Evidence

19
DA
Dotcheva AglikaChief Financial Officer
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$1.07M
180.0K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

19
CJ
Colella JosephSVP and General Counsel
ENTGENTEGRIS INC
Option exercise
M$384K
3,916 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

19
LW
Landman WilliamDirector
ZETAZeta Global Holdings Corp.
Disposition to issuer
D$632K
22.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

19
FA
Feldman AssafDirector, Chief Strategy Officer - Tech, 10% Owner
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$1.35M
206.1K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

19
MB
Moss BrandonDirector, Chief Executive Officer
SHLSShoals Technologies Group, Inc.
Tax withholding
F$850K
104.4K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

17
SE
Smolyansky Edward10% Owner
LWAYLifeway Foods, Inc.
Open-market sale
SELL$822
31 sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

17
DB
Derakhshan BehradChief Business Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
5,781 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

17
GM
Gonzales MelissaDirector
OWLTOwlet, Inc.
Grant or award
A—
26.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

17
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
200.0K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

17
GM
Goodwin William Carroll MurphyChief Legal & Strategy Officer
OKLOOklo Inc.
Option exercise
M—
20.7K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

17
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
5,781 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

17
VL
Vacirca Jeff LDirector
CAICaris Life Sciences, Inc.
Grant or award
A—
13.2K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

17
DB
Derakhshan BehradChief Business Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
7,500 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

17
DL
Durr LauraDirector
OWLTOwlet, Inc.
Grant or award
A—
26.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

16
WJ
Weaver JesseChief Financial Officer
HLLYHolley Inc.
Tax withholding
F$103K
32.5K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

16
KJ
Keough JosephDirector
TILEINTERFACE INC
Gift
G—
8,442 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

16
RH
Ramani HiteshChief Accounting Officer
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$419K
25.0K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

16
RS
Ravella SatishChief Accounting Officer
ZETAZeta Global Holdings Corp.
Gift
G—
25.8K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

16
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$446K
16.1K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

16
TJ
Taylor Randy JSee Remarks
USFDUS Foods Holding Corp.
Option exercise
M$180K
5,199 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

16
DA
Dotcheva AglikaChief Financial Officer
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$522K
80.0K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

16
GL
Gimbel LisaCHIEF ACCOUNTING OFFICER
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$8,750
500 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

16
TJ
Taylor Randy JSee Remarks
USFDUS Foods Holding Corp.
Option exercise
M$216K
6,431 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

15
RG
Rottmann Scott GlennPresident
RGPRESOURCES CONNECTION, INC.
Tax withholding
F$20K
4,739 sh
Aug 10, 2026Aug 14, 2026
traded Aug 10, 2026
+4dSEC Form 4

Evidence

15
MD
Malhotra DeepakDirector
TMRCDyTb, LLC
Disposition to issuer
D—
244.8K sh
Aug 7, 2026Aug 14, 2026
traded Aug 7, 2026
+7dSEC Form 4

Evidence

15
MG
Marchese Anthony G.Director
TMRCDyTb, LLC
Disposition to issuer
D—
5.17M sh
Aug 7, 2026Aug 14, 2026
traded Aug 7, 2026
+7dSEC Form 4

Evidence

15
BS
Beigle Jonathan ScottDirector
TMRCDyTb, LLC
Disposition to issuer
D—
60.8K sh
Aug 7, 2026Aug 14, 2026
traded Aug 7, 2026
+7dSEC Form 4

Evidence

15
HE
Hulse Donald EdwardDirector
TMRCDyTb, LLC
Disposition to issuer
D—
176.6K sh
Aug 7, 2026Aug 14, 2026
traded Aug 7, 2026
+7dSEC Form 4

Evidence

15
WC
Wall Cecil CDirector
TMRCDyTb, LLC
Disposition to issuer
D—
1.70M sh
Aug 7, 2026Aug 14, 2026
traded Aug 7, 2026
+7dSEC Form 4

Evidence

15
WC
Wall Cecil CDirector
TMRCDyTb, LLC
Disposition to issuer
D—
47.1K sh
Aug 7, 2026Aug 14, 2026
traded Aug 7, 2026
+7dSEC Form 4

Evidence